EVENTS
2023/11/06
23116-7第9回ゼブラフィッシュ・メダカ創薬研究会（ZDMM2023）
2023/11/06
新しいハイスループット個別蛋白尿治療薬スクリーニングシステムの構築と応用
2023/04/22
ゼブラフィッシュ創薬のグローバル展開
2023/01/01
230101謹賀新年三重大学海岸より
2022/11/18
日本患者由来がんモデル学会学術集会２０２２
》Patient-Derived Cancer Xenograft Zebrafish Model (PDXZ) for Quantitative Drug Discovery Screening
2021/10/13
BioJapan2021: Oct 13-15, 2021
We developed novel zebrafish model for patient-derived xenograft (PDXZ), and demonstrated that PDXZ has high rate and speed of engraftment in normal zebrafish when the immune system is immature, requires less than 100 cancer cells for transplantation, and can be quantitatively analyzed in 2 days. We report on drug efficacy screening system that can be quantitatively analyzed within a week.
関連リンク
関連ファイル
Patient-Derived Cancer Xenograft Zebrafish Model (PDXZ) for Quantitative Drug Discovery Screening